Org 3770 versus amitriptyline: A 6‐week randomized double‐blind multicentre trial in hospitalized depressed patients
- 1 May 1995
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 10 (3) , 173-180
- https://doi.org/10.1002/hup.470100302
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The α2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivoEuropean Journal of Pharmacology, 1994
- Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdosesThe Lancet, 1993
- Possible Monoamine Oxidase Inhibitor-Serotonin Uptake Inhibitor InteractionJournal of Clinical Psychopharmacology, 1993
- Treatments of Depression and the Functional Capacity to WorkArchives of General Psychiatry, 1992
- The effect of adrenergic drugs on serotonin metabolism in the nucleus raphe dorsalis of the rat, studied by in vivo voltammetryEuropean Journal of Pharmacology, 1992
- Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks.BMJ, 1992
- REMERGON EFFICACY IN MAJOR DEPRESSIVE EPISODE: A RANDOMIZED, DOUBLE-BLIND, CLOMIPRAMINE-CONTROLLED STUDY IN 174 FRENCH HOSPITALIZED PATIENTS.Clinical Neuropharmacology, 1992
- The Safety of AntidepressantsDrugs, 1992
- Fatal toxicity of antidepressant drugs in overdose.BMJ, 1987
- The Diagnosis of Depressive Syndromes and the Prediction of E.C.T. ResponseThe British Journal of Psychiatry, 1965